Elanco Animal Health has selected downtown Indianapolis as the location for its future global consolidated operations.
Elanco says the move represents another step in the company’s plan to capture economic value through global footprint consolidation after its August acquisition of Bayer’s animal health business.
The company will relocate its global headquarters, currently located in Greenfield, Indiana, to a 45-acre former industrial site in the southwest corner of Indianapolis. Elanco says it will retain 1,600 jobs and create more than 570 jobs over the next ten years.
